Seeking Alpha22d
Valneva Is A 'Buy' As A First-Mover In Chikungunya
Valneva's Ixchiq is the first and only approved Chikungunya vaccine in the US, Canada, and EU. Ixiaro is for Japanese encephalitis, and it’s today VALN’s main revenue contributor. But its near ...
PMLiVE9d
MHRA approves Valneva’s chikungunya vaccine Ixchiq for use in adults
Ixchiq is now the first vaccine approved in the UK to prevent disease caused by the chikungunya virus (CHIKV) in individuals aged 18 years and older. CHIKV is a mosquito-borne viral disease that ...
Hosted on MSN24d
Valneva gains after new Phase 3 data for chikungunya vaccine in adolescents
In November, the U.S. FDA approved Ixchiq as the world’s first chikungunya vaccine. The company reported 28-day and six-month data from the VLA1553-321 trial in 2023 and 2024, respectively.
The Pharma Letter9d
UK grants approval for Valneva’s chikungunya vaccine
French biotech Valneva has secured marketing approval in the UK for its chikungunya vaccine, Ixchiq (chikungunya vaccine), ...
Pharmabiz8d
UK MHRA grants marketing authorization to Valneva’s chikungunya vaccine, Ixchiq
Valneva SE, a specialty vaccine company, announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization in the United Kingdom (UK) for the world’s ...
Yahoo Finance10d
Valneva Receives Marketing Authorization in the UK for the World’s First Chikungunya Vaccine, IXCHIQ®
Saint Herblain (France), February 5, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the Medicines and Healthcare products Regulatory ...
Yahoo Finance25d
Favorable VLA1553-321 Phase 3 Study Results Boost VALN Stock
For investors’ note, IXCHIQ is the world’s first and only licensed chikungunya vaccine available to address this significant unmet medical need. The trial data supports and strengthens the ...
Seeking Alpha24d
Valneva gains after new Phase 3 data for chikungunya vaccine in adolescents
Valneva (NASDAQ:VALN) ADRs traded higher in the premarket on Tuesday after the French biotech posted additional data for its FDA-approved chikungunya vaccine, Ixchiq, from a Phase 3 trial for ...
Morningstar9d
Valneva Receives Marketing Authorization in the UK for the World’s First Chikungunya Vaccine, IXCHIQ®
The approval is based on IXCHIQ®’s final pivotal Phase 3 data ... We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and ...
ADVFN2d
Valneva Receives Marketing Authorization in the UK for the World’s First Chikungunya Vaccine, IXCHIQ®
The approval is based on IXCHIQ®’s final pivotal Phase 3 data, published in The Lancet, which included more than 4,000 participants and demonstrated that a single dose of the live-attenuated ...
ADVFN2d
Valneva Receives Marketing Authorization in the UK for the World’s First Chikungunya Vaccine, IXCHIQ®
Juan Carlos Jaramillo, M.D., Chief Medical Officer of Valneva, commented, “This latest approval is a further recognition of IXCHIQ ® ’s strong product profile and the medical need for a ...